Which of the statements about the 2025 American College of Rheumatology guideline for the treatment of systemic lupus ...

Lupus affects women at disproportionately high rates— roughly 9 out of 10 patients are female —and research consistently ...

Telitacicept, a dual inhibitor of the cytokines B-lymphocyte stimulator and a proliferation-inducing ligand, showed efficacy ...

An aggressive strain of influenza is surging in Sarasota, Florida, with one hospital reporting a 30% increase in cases. This ...

With AI interpreting lab results for a growing number of patients, clinicians must provide context and caution and prepare ...

Researchers reveal structure of ancient viral protein appearing in breast cancer, lupus, and ALS, opening new paths for ...

Lupus is an unpredictable and misunderstood autoimmune disease. It is difficult to diagnose, hard to live with, and a challenge to treat. Lupus has a range of symptoms, and strikes without warning.

Lupus is often marked by flares, which is when symptoms are usually more obvious.

Johnson & Johnson (JNJ) stock is in focus as the company's experimental therapy for systemic lupus erythematosus hits the ...

Objective This study aimed to evaluate the prevalence and predictors of cardiovascular disease (CVD), chronic kidney disease ...

Objectives The European Alliance of Associations for Rheumatology (EULAR) recommendations for the management of systemic lupus erythematosus (SLE) and lupus nephritis provide important guidance for ...

Autolus Therapeutics is working with Cellares to assess automated CAR T manufacturing to support rising demand for its ...